Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00406614 · ClinicalTrials.gov registry record · NA

Health Literacy-Focused Program to Improve Blood Pressure Control in Korean Americans

A NA study of Hypertension, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
360
Enrollment target
1
Study location

NCT00406614 is a NA study of Hypertension that has completed, run by University of Texas at Austin. The registered enrollment target is 360 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00406614, a NA study of Hypertension, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
360 participants
Enrollment target
1
Study location

Study Summary

Many Korean Americans are at risk for developing high blood pressure. Low health literacy levels may play a role in this risk. The purpose of this study is to evaluate a literacy-focused program aimed at reducing blood pressure levels in older Korean Americans.

Conditions Studied

Interventions

  • BEHAVIORAL Health Literacy-Focused High Blood Pressure Intervention

Study Locations (1)

Maryland

  • Korean Resource Center - Ellicott City

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2007-09
Est. Completion 2011-07
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT00406614

The ClinicalTrials.gov registry entry for NCT00406614 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (90% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Health Literacy-Focused High Blood Pressure Intervention is the first listed.

NCT00406614 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00406614 about?

NCT00406614 is a clinical study titled "Health Literacy-Focused Program to Improve Blood Pressure Control in Korean Americans". Many Korean Americans are at risk for developing high blood pressure. Low health literacy levels may play a role in this risk. The purpose of this study is to evaluate a literacy-focused program aimed at reducing blood pressure levels in older Korean Americans.

What is the current status of trial NCT00406614?

This trial is currently completed. It is a NA study. The enrollment target is 360 participants. The study started on 2007-09. Estimated completion is 2011-07.

What conditions does trial NCT00406614 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00406614?

The interventions under investigation include: Health Literacy-Focused High Blood Pressure Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00406614?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00406614 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.